Outsourced Pharma Conference Boston
Outsourced Pharma is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing.
Managing Director Jason Foss will be speaking on the panel: Does your risk management plan satisfy the FDA and SEC? at Outsourced Pharma Conference in Boston, USA.
Does Your Risk Management Plan Satisfy The FDA and SEC?
Regulatory scrutiny of your outsourcing activities isn’t limited to the FDA. The SEC is paying more attention to how you manage and disclose operational risks. Any drug developer receiving funding needs to listen to this panel discuss risk management and disclosure, best practices for data integrity and IP protection, and supply and quality agreements.
- Ranjani Prabhakara, Team Leader | FDA
- Robert Di Scipio, CEO | Skyland Analytics, Inc.
- John Lee, SVP, Pharmaceutical Development | Decibel Therapeutics
- Jason Foss, Managing Director | Results Healthcare
- Stephen Kennedy, EVP & COO | Histogenics (Moderator)